Intravenous injection of PSD-95 inhibitors (Tat-NR2B9c (SDV) or Tat-NR2B9c (TDV)) 3 h after stroke can reduce infarct size and improve neurological function in a stroke with a hyperthermic rat model [28]. This evidence concerns the gene DLG4 and Stroke.